血液系统恶性肿瘤中靶向 ROR1 的治疗进展
Therapeutic advances in the targeting of ROR1 in hematological cancers.
65.1分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Therapeutic advances in the targeting of ROR1 in hematological cancers.
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。